HERBST SETH is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Seth Herbst is identified as a director of Dyadic International Inc (DYAI) in the company's SEC filing. Dyadic is a worldwide biotechnology platform company that has developed a gene expression platform based on the Thermothelomyces heterothallica fungus (C1) and licenses it for industrial applications. The filing shows no stock purchases or sales by Herbst as of 2026-01-06.
Role
Director
Notability
30/100
Board memberships
Dyadic International Inc
Awards & honors
Serves on the board of directors of Dyadic International Inc
Seth Herbst is identified as a director of Dyadic International Inc (DYAI) in the company's SEC filing. Dyadic is a worldwide biotechnology platform company that has developed a gene expression platform based on the Thermothelomyces heterothallica fungus (C1) and licenses it for industrial applications. The filing shows no stock purchases or sales by Herbst as of 2026-01-06.…
Where can I see all of HERBST SETH's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
